130 related articles for article (PubMed ID: 16341038)
1. Mutational screen reveals a novel JAK2 mutation, L611S, in a child with acute lymphoblastic leukemia.
Kratz CP; Böll S; Kontny U; Schrappe M; Niemeyer CM; Stanulla M
Leukemia; 2006 Feb; 20(2):381-3. PubMed ID: 16341038
[No Abstract] [Full Text] [Related]
2. The V617F mutation in Jak2 is not found in childhood acute lymphoblastic leukaemia.
Sulong S; Case M; Minto L; Wilkins B; Hall A; Irving J
Br J Haematol; 2005 Sep; 130(6):964-5. PubMed ID: 16156866
[No Abstract] [Full Text] [Related]
3. Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders.
McClure R; Mai M; Lasho T
Leukemia; 2006 Jan; 20(1):168-71. PubMed ID: 16270039
[No Abstract] [Full Text] [Related]
4. Mutations of N-RAS, FLT3 and p53 genes are not involved in the development of acute leukemia transformed from myeloproliferative diseases with JAK2 mutation.
Suzuki M; Abe A; Kiyoi H; Murata M; Ito Y; Shimada K; Morishita Y; Kinoshita T; Naoe T
Leukemia; 2006 Jun; 20(6):1168-9. PubMed ID: 16557239
[No Abstract] [Full Text] [Related]
5. JAK2 Val617Phe activating tyrosine kinase mutation in juvenile myelomonocytic leukemia.
Tono C; Xu G; Toki T; Takahashi Y; Sasaki S; Terui K; Ito E
Leukemia; 2005 Oct; 19(10):1843-4. PubMed ID: 16079889
[No Abstract] [Full Text] [Related]
6. [A recurrent mutation of the JAK2 gene in chronic myeloproliferative disorders].
Berger R
Pathol Biol (Paris); 2006 May; 54(4):182-4. PubMed ID: 16084028
[No Abstract] [Full Text] [Related]
7. JAK the trigger.
Mahon FX
Oncogene; 2005 Nov; 24(48):7125-6. PubMed ID: 16007127
[TBL] [Abstract][Full Text] [Related]
8. JAK2 V617F: a single mutation in the myeloproliferative group of disorders.
McLornan D; Percy M; McMullin MF
Ulster Med J; 2006 May; 75(2):112-9. PubMed ID: 16755940
[No Abstract] [Full Text] [Related]
9. A quantitative assay for JAK2(V617F) mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis.
Vannucchi AM; Pancrazzi A; Bogani C; Antonioli E; Guglielmelli P
Leukemia; 2006 Jun; 20(6):1055-60. PubMed ID: 16572198
[TBL] [Abstract][Full Text] [Related]
10. The V617F JAK2 mutation and the myeloproliferative disorders.
Percy MJ; McMullin MF
Hematol Oncol; 2005; 23(3-4):91-3. PubMed ID: 16285006
[TBL] [Abstract][Full Text] [Related]
11. A single amino acid change A91V in perforin: a novel, frequent predisposing factor to childhood acute lymphoblastic leukemia?
Santoro A; Cannella S; Trizzino A; Lo Nigro L; Corsello G; Aricò M
Haematologica; 2005 May; 90(5):697-8. PubMed ID: 15921391
[TBL] [Abstract][Full Text] [Related]
12. A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders.
Di Ianni M; Moretti L; Del Papa B; Gaozza E; Bell AS; Falzetti F; Tabilio A
Leukemia; 2006 Oct; 20(10):1895-7. PubMed ID: 16900208
[No Abstract] [Full Text] [Related]
13. Screening of JAK2 V617F mutation in multiple myeloma.
Fiorini A; Farina G; Reddiconto G; Palladino M; Rossi E; Za T; Laurenti L; Giammarco S; Chiusolo P; Leone G; Sica S
Leukemia; 2006 Oct; 20(10):1912-3. PubMed ID: 16871278
[No Abstract] [Full Text] [Related]
14. Detection of the JAK2 V617F mutation by LightCycler PCR and probe dissociation analysis.
Lay M; Mariappan R; Gotlib J; Dietz L; Sebastian S; Schrijver I; Zehnder JL
J Mol Diagn; 2006 Jul; 8(3):330-4. PubMed ID: 16825505
[TBL] [Abstract][Full Text] [Related]
15. The effect of the JAK2 V617F mutation on PRV-1 expression.
Mnjoyan Z; Yoon D; Li J; Delhommeau F; Afshar-Kharghan V
Haematologica; 2006 Mar; 91(3):411-2. PubMed ID: 16503546
[TBL] [Abstract][Full Text] [Related]
16. Chronic neutrophilic leukemia with an associated V617F JAK2 tyrosine kinase mutation.
Mc Lornan DP; Percy MJ; Jones AV; Cross NC; Mc Mullin MF
Haematologica; 2005 Dec; 90(12):1696-7. PubMed ID: 16330446
[TBL] [Abstract][Full Text] [Related]
17. The acute lymphoblastic leukemia-associated JAK2 L611S mutant induces tumorigenesis in nude mice.
Funakoshi-Tago M; Tago K; Sumi K; Abe M; Aizu-Yokota E; Oshio T; Sonoda Y; Kasahara T
J Biol Chem; 2009 May; 284(19):12680-90. PubMed ID: 19289461
[TBL] [Abstract][Full Text] [Related]
18. JAK2 V617F mutation analysis in different myeloid lineages (granulocytes, platelets, CFU-MK, BFU-E and CFU-GM) in essential thrombocythemia patients.
Florensa L; Bellosillo B; Besses C; Puigdecanet E; Espinet B; Pérez-Vila E; Longarón R; Vilà RM; Solé F; Serrano S
Leukemia; 2006 Oct; 20(10):1903-5. PubMed ID: 16888614
[No Abstract] [Full Text] [Related]
19. JAK2 mutations in myeloproliferative disorders.
Tefferi A; Lasho TL; Gilliland G
N Engl J Med; 2005 Sep; 353(13):1416-7; author reply 1416-7. PubMed ID: 16192494
[No Abstract] [Full Text] [Related]
20. FLT3 mutations in childhood acute lymphoblastic leukemia at first relapse.
Wellmann S; Moderegger E; Zelmer A; Bettkober M; von Stackelberg A; Henze G; Seeger K
Leukemia; 2005 Mar; 19(3):467-8. PubMed ID: 15674414
[No Abstract] [Full Text] [Related]
[Next] [New Search]